[Calpernia]

http://www.freerepublic.com/focus/news/1458685/posts

Biotech Company Fined $500,000 in Chicken Virus Smuggling Case Portsmouth Herald News ( New Hampshire) ^ | 7 August 2005 | Staff

Posted on 08/07/2005 1:51:06 PM EDT by Our_Man_In_Gough_Island

BANGOR, Maine - A Maine biotechnology company has been fined $500,000 for illegally smuggling a chicken virus into the United States from Saudi Arabia so it could create a vaccine.

U.S. District Judge John Woodcock on Friday followed the prosecutors' recommended fine against Maine Biological Laboratory of Winslow. The fine includes more than $319,000 in profits the firm made on the illegal vaccine.

(snip)

Maine Biological Laboratories (MBL)
PO Box 255
Waterville ME 04903-0255

Phone:

207-873-3989 FAX:	207-873-4975 Tollfree:	800-639-1582 Internet:http://www.mainebiolab.com/
Founded:1957 ----------------------------------------------------------- Now look at this, NOTE address and web url: Lohmann Animal Health International PO Box 255 Waterville, ME, 04903-0255 Tel.: (207) 873-3989 Fax: (207) 873-4975 Contact: Mr. David Zacek http://www.mainebiolab.com From: http://www.regione.sicilia.it/Cooperazione/pmi/paese/all4usb.pdf ------------------------------------------------------------ Lohmann Animal Health International is funded by Monsanto Company through NIH grants, HEINZ-Lohmann-Strasse, Pfizer.

[Calpernia]

http://www.freerepublic.com/focus/news/1573646/posts?page=64#64

[Calpernia]

You mentioning the Atta recall on that thread last night jarred my memory of MBL from Maine. See post 64. thanks!

[Calpernia]

64

[Calpernia]

64

[Carry_Okie]

Thrilling.

Thx for the post.

[Calpernia]

Post 64 in response to our freep mail.

[Calpernia]

In reference to our freep mail, look at post 64.

[jer33 3]

Animal Health and Food Safety Vaccines

Additionally, AVANT has appointed Lohmann Animal Health International (LAHI) as the exclusive distributor of its Megan Health poultry vaccines in North America, which AVANT believes leverages the value of its oral vaccine technology in a significant market opportunity outside of AVANT's own focus on human health care.

"AVANT has made significant progress in leveraging the value of its vaccine technologies for multiple human healthcare needs, as well as applications in animal health and food safety," commented Dr. Ryan.

http://phx.corporate-ir.net/phoenix.zhtml?c=93243&p=irol-newsArticle&t=Regular&id=348074&